Home Efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in lung squamous cell carcinoma patients underwent conventional chemoradiotherapy
Article Open Access

Efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in lung squamous cell carcinoma patients underwent conventional chemoradiotherapy

  • Yanzhen Ji , Shuli Luan , Xiaoping Yang , Bin Yin , Xiaojie Jin , Haiyan Wang and Wenqing Jiang EMAIL logo
Published/Copyright: April 3, 2023
Download Article (PDF)
Open Medicine
From the journal Open Medicine Volume 18 Issue 1

Abstract

Bronchoscopy has been widely used for the therapy of lung cancer. This study aimed to evaluate the therapeutic efficacy and adverse reactions of bronchoscopic intratumoral injection of endostar and cisplatin in patients with lung squamous cell carcinoma (LSCC). A total of 40 LSCC patients who underwent conventional chemoradiotherapy were included in this study, and 20 of them received a bronchoscopic injection of endostar and cisplatin as an additive therapeutic modality (treatment group). The clinical response rate, progression-free survival (PFS), and adverse reactions of the patients were compared and analyzed. The treatment group had better short- and long-term therapeutic efficacy compared to the control group, but no significant differences were observed between the two therapeutic regimens in adverse reactions. Elderly and advanced LSCC patients had worse therapeutic efficacy and a high probability of adverse reactions after the therapy. Collectively, our analysis data demonstrated that the bronchoscopic intratumoral injection of endostar and cisplatin had improved therapeutic efficacy, and the cardiovascular adverse reactions were within the controllable range in the treatment of LSCC in clinical practices.

Keywords: lung squamous cell carcinoma; bronchoscopy; endostar; cisplatin; efficacy; adverse reactions

1 Introduction

Lung cancer, as a kind of frequent malignant tumor, accounts for the largest number of cancer-related deaths [1]. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, and lung squamous cell cancer (LSCC) accounts for about 30% of NSCLC [2]. Surgical treatment is preferred for those lung cancer patients who can still undergo surgery, but most of the patients have already reached advanced stages when they are diagnosed [3]. As a result, there are about 70% of patients lose the chance to undergo surgical treatment [4]. Therefore, systemic chemotherapy or transarterial chemotherapy combined with radiotherapy has become the major method for the treatment of lung cancer [5]. However, compared to small cell lung cancer (SCLC), NSCLC is not sensitive to chemotherapy, especially for LSCC [6]. Thus, specific and effective therapeutic approaches are necessary for the treatment of LSCC.

Bronchoscopes are suitable for observing pulmonary lobes, segment and subsegment bronchial lesions, biopsy sampling, bacteriology, and cytology examinations [7]. The bronchoscope is attached to a biopsy sampling structure, which helps detect early lesions and carry out internal surgery, such as polyp removal [8]. It is considered a good precision instrument for the research of bronchial and lung diseases. With the development of bronchoscopy in recent years, endoscopic interventional therapy plays an increasingly important role in the treatment of pulmonary diseases, especially lung cancer [9]. The intratumoral injection of anti-cancer drugs with the guidance of a bronchoscope is characterized by a simple operation and a high success rate, making it an efficient therapeutic method for cancer treatment [10]. However, the efficacy and safety evaluations of this method still need to be evaluated to provide more clinical evidence for its application.

Cisplatin is widely used as an anti-tumor drug in various malignant tumors, especially in NSCLC. It can bind to DNA, leading to the destruction of DNA function and inhibition of cell mitosis [11]. Recent studies have reported the considerable therapeutic efficacy of endobronchial intratumoral chemotherapy using cisplatin in lung cancer [12]. Next to chemotherapy, anti-angiogenic therapy also received increasing attention. The combinations of chemotherapy and anti-angiogenic therapy have presented to benefit patients with malignant tumors [13]. Angiogenesis plays a critical and promoting role in the progression of malignancies [14]. Anti-angiogenic agents, such as endostar (rh-endostatin), bevacizumab (anti-vascular endothelial growth factor A), and ramucirumab (anti-vascular endothelial growth factor R), have been applied for anti-tumor therapies, especially for tumors with advanced clinical stages [15]. It has been reported that the combination of endostar and chemotherapy significantly improves the clinical outcomes of cancer patients [16,17].

Our previous study found that the intratumoral injection of cisplatin and endostar with the guidance of a bronchoscope is an effective and safe adjuvant method to alleviate malignant central airway obstruction [18]. This study collected and analyzed the clinical data of LSCC patients who underwent conventional chemoradiotherapy combined with bronchoscopic intratumoral injection of endostar and cisplatin. The short- and long-term therapeutic efficacy and application safety were evaluated, and the clinical characteristics of patients that might affect efficacy and safety were further assessed. The analysis results of this study are expected to provide clinical evidence and data for the use of bronchoscopy in LSCC treatment.

2 Materials and methods

2.1 Study population

This study retrospectively analyzed 40 patients with LSCC who were admitted to Hiser Medical Center of Qingdao from December 2016 to June 2017. Twenty-eight males and 12 females were included, and the average age of the patients was 70.8 ± 1.8 years. According to tumor, node, metastasis (TNM) staging criteria, there were four cases of stage IIIB and 36 cases of stage IV. The inclusion criteria were as follows: (1) age of 18–80 years; (2) pathologically and/or cytologically confirmed as LSCC; (3) unresectable LSCC with central intraluminal growth; (4) expected survival time was more than 3 months; and (5) patients can understand the content of the study and had signed the informed consent. Following were exclusion criteria: (1) age >80 years or <18 years; (2) tracheal or carinal tumor obstructing more than 3/4 of the lumen; (3) external pressure airway stenosis; (4) severe arrhythmia, acute myocardial ischemia, and uncontrolled hypertensive crisis; (5) coagulation dysfunction; (6) severe organ dysfunction; (7) allergy to anesthetics; (8) pregnant and lactating women; and (9) intolerance to bronchoscopy and severe reaction to chemotherapy. All patients were considered unsuitable for surgical resection after multidisciplinary consultation and grouped into control group (n = 20) and treatment group (n = 20) based on the therapy received. Patients in the control group received conventional chemoradiotherapy, and patients in the treatment group received conventional chemoradiotherapy combined with bronchoscopic intratumoral injection of endostar and cisplatin. Each patient signed informed an consent form, and the study protocols were approved by the Ethics Committee of the Hiser Medical Center of Qingdao (#0015873).

2.2 Treatment regimens

For the control group, patients received conventional chemoradiotherapy, specifically systemic intravenous docetaxel combined with cisplatin or gemcitabine combined with cisplatin chemotherapy combined with radiotherapy. Each therapy cycle contained 21 days, and two consecutive cycles of chemotherapy were performed. Before the first cycle and after the second cycle, electronic bronchoscopy was used for tumor removal and biopsy.

For the treatment group, in addition to the conventional chemoradiotherapy, an electronic bronchoscope (Olympus BR-1T260) was used for the therapy. According to the routine operation of bronchoscopy, 2% lidocaine spray was used to achieve painless sedation before the operation, and a continuous intravenous infusion of propofol remifentanil was used during the operation. Cisplatin (20 mg) was dissolved in normal saline to 4 mL, and 15 mg endostar was also dissolved to 4 mL using normal saline. Under conventional chemoradiotherapy, endostar and cisplatin were locally injected with bronchoscopy on the third day (D3) and tenth day (D10) of each chemotherapy cycle. Routine bronchoscopy was performed, and bronchoscopic ablation was performed. After that, endostar and cisplatin were injected into the center and periphery of the residual tumors with four to six injection points. The penetration depth was 3–4 mm, and cisplatin and endostar with a volume of 0.5 mL were injected alternately each time. Two consecutive cycles of chemotherapy were applied.

The above two groups of treatment regimens were evaluated after two cycles of chemotherapy. At any time during the study, if there was objective evidence of tumor progression or serious adverse events, the treatment would be terminated.

2.3 Evaluation of therapeutic efficacy

After two cycles of therapy, therapeutic efficacy was evaluated and compared. The short-term therapeutic efficacy was defined as follows: complete remission (CR), the complete elimination of tumors in the airway, and lasted for 1 month; significant remission (SR), where the minimal diameter of tracheobronchial stenosis increased by more than 30% after the treatment, lasting for 1 month; minor remission (MR), where the minimal diameter of tracheobronchial stenosis increased by less than 30% after the treatment, lasting for 1 month; and no response (NR), where the minimal diameter of tracheobronchial stenosis decreased by more than 30%. The clinical remission rate (CRR) was calculated as (CR + SR)/total cases × 100%, and the clinical beneficial rate (CBR) was calculated as (CR + SR + MR)/total cases × 100%.

For long-term therapeutic efficacy, the progression-free survival (PFS) of each patient was evaluated. All the patients were followed up to record the progression of the disease, and PFS was defined as the time between initial chemotherapy and disease progression or death.

2.4 Adverse reaction data collection

Adverse reaction evaluation was performed in accordance with the Common Terminology Criteria for Adverse Events (CTCAE) by the National Cancer Institute of the USA [19]. Myelosuppression, liver dysfunction, and gastrointestinal reactions presented after the treatment were analyzed. To evaluate myelosuppression, cases of leucopenia, neutropenia, haemoglobinia, and thrombocytopenia were recorded. The concentrations of glutamic-pyruvic transaminase (ALT) and aspartate transaminase (AST) were measured to evaluate liver function. Gastrointestinal reactions mainly included nausea and emesis. In addition, the cardiovascular adverse reactions were evaluated using an electrocardiogram. Electrocardiographic abnormalities included changes in the ST segment and T wave (ST-T changes). Blood pressure fluctuation was defined as that which increased or decreased by ≥20 mmHg compared with that before treatment (excluding fluctuation within the normal range).

2.5 Statistical analysis

SPSS statistical software 26.0 was used to perform statistical analyses in this study. The data were expressed as frequency and/or percentage and analyzed using the Chi-square test or F test. The PFS of patients was analyzed using the Kaplan–Meier method, and the distributions between the curves were compared using the log-rank test. A difference with P < 0.05 indicated statistically significant.

3 Results

3.1 Baseline characteristics of the LSCC patients

The baseline features of the patients were listed in Table 1. Patients in the treatment group were 70.6 ± 1.2 years old and contained 15 males and five females. The control group was age- and gender-matched with the treatment group (both P > 0.05), which contained 13 males and seven females and aged 70.9 ± 2.2 years. There were 15 former smokers in the treatment group and 14 in the control group. Both groups had two cases with IIIB-stage tumors and 18 cases with IV-stage tumors.

Table 1

Baseline characteristics of the study population

Characteristics Total no. Control group (n = 20) Treatment group (n = 20) P value
Age (years) 0.752
 ≤70 19 10 9
 >70 21 10 11
Gender 0.490
 Female 12 7 5
 Male 28 13 15
Smoking 0.723
 Never 11 6 5
 Ever 29 14 15
TNM stage 1.000
 IIIB 4 2 2
 IV 36 18 18

3.2 Short- and long-term therapeutic efficacy between the two groups

After the two cycles of therapy, short-term therapeutic efficacy was evaluated. There were six SR cases, 10 MR cases, and four NR cases in the control group, and the CRR and CBR were 30 and 80%, respectively. No CR patients were observed in this group. For the treatment group, all the patients had varying degrees of remission, and there were four CR cases, 14 SR cases, and two MR cases with CRR and CBR of 90 and 100%, respectively. Compared to the control group, the patients in the treatment group showed significantly better efficacy (P < 0.001, Table 2).

Table 2

Comparison of short-term therapeutic efficacy between the two groups

Groups Total no. CR SR MR NR CCR(%) CBR(%) P value
Control group 20 0 6 10 4 30 80 0.001
Treatment group 20 4 14 2 0 90 100

CCR, (CR + SR)/total cases × 100%; CBR, (CR + SR + MR)/total cases × 100%.

This study followed up on the disease progression of patients to evaluate long-term efficacy in the two groups. The follow-up time was 5.6 ± 2.8 months (range: 2–14 months) for the control group and 8.7 ± 3.2 (range: 4–18 months) for the treatment group. The median PFS of the control group was 4.8 months, the median PFS of the treatment group was 8.0 months, and the PFS of the treatment group was markedly better than that of the control group (log-rank P = 0.005, Figure 1).

Figure 1 PFS of LSCC patients underwent different therapeutic methods. log-rank P = 0.005.
Figure 1

PFS of LSCC patients underwent different therapeutic methods. log-rank P = 0.005.

3.3 Adverse reactions after the treatment of the two groups

Patients in the control group developed 12 leucopenia, 11 neutropenia, nine haemoglobinia, three thrombocytopenia, four ALT increase, three AST increase, six nausea, and five emesis cases. No cardiovascular adverse reaction was observed in this group. In the treatment group, there were 13 leucopenia, 10 neutropenia, nine haemoglobinia, one thrombocytopenia, three ALT increase, three AST increase, four nausea and four emesis cases, and one case with ST-T change and two cases with blood pressure fluctuation. According to the CTCAE, the adverse reactions (in addition to the cardiovascular adverse reactions) are graded into I–II and III–IV grades (Table 3), and no significant differences were observed in these reactions between the two groups (all P > 0.05).

Table 3

Comparison of adverse reactions between the two groups after therapy

Parameters Control group (n = 20) Treatment group (n = 20) P value
Leucopenia 12 13 0.801
 I–II 6 8
 III–IV 6 5
Neutropenia 11 10 0.907
 I–II 7 7
 III–IV 4 3
Haemoglobinia 9 9 0.819
 I–II 7 8
 III–IV 2 1
Thrombocytopenia 3 1 0.292
 I–II 3 1
 III–IV 0 0
Increased ALT 4 3 0.677
 I–II 4 3
 III–IV 0 0
Increased AST 3 3 1.000
 I–II 3 3
 III–IV 0 0
Nausea 6 4 0.465
 I–II 6 4
 III–IV 0 0
Emesis 5 4 0.705
 I–II 5 4
 III–IV 0 0
ST-T changes 0 1 0.311
Blood pressure fluctuation 0 2 0.147

3.4 Relationship between therapeutic efficacy and clinical characteristics in the treatment group

To find the factors that might affect the therapeutic efficacy of the treatment group, the clinical responses of patients were compared between patients with different clinical features. As shown in Table 4, patients aged ≤70 years had more cases with CR and SR conditions compared with those aged >70 years (P = 0.030). All of the two IIIB-stage patients showed CR and were significantly different in clinical responses from the patients with IV tumors (P = 0.012).

Table 4

Association of short-term efficacy with clinical data in the treatment group

Variables CR SR MR P value
Age (years) 0.030*
 ≤70 4 5 0
 >70 0 9 2
Gender 0.683
 Female 1 4 0
 Male 3 10 2
Smoking 0.683
 Never 1 3 1
 Ever 3 11 1
TNM stage 0.012*
 IIIB 2 0 0
 IV 2 14 2

*P < 0.05.

In addition, the PFS curves were further plotted in patients with different clinical data, the PFS in the population >70 years old was poorer than that in the patients who were ≤70 years old (log-rank P = 0.009, Figure 2a). No differences were found in the PFS between patients with different genders or smoking history (log-rank P > 0.05, Figure 2b and c). Patients at IIIB stage had a better PFS compared to those at the IV stage (log-rank P = 0.021, Figure 2d).

Figure 2 Association of clinical data with the PFS of LSCC patients in the treatment group. (a) PFS of patients with different ages (log-rank P = 0.009). (b) PFS of patients with different gender (log-rank P = 0.685). (c) PFS of patients with different smoking history (log-rank P = 0.665). (d). PFS of patients with different TNM stages (log-rank P = 0.021).
Figure 2

Association of clinical data with the PFS of LSCC patients in the treatment group. (a) PFS of patients with different ages (log-rank P = 0.009). (b) PFS of patients with different gender (log-rank P = 0.685). (c) PFS of patients with different smoking history (log-rank P = 0.665). (d). PFS of patients with different TNM stages (log-rank P = 0.021).

3.5 Reverse reactions in patients with different clinical features in the treatment group

The patients in the treatment group were divided into multiple subgroups based on their clinical features, and the adverse reactions were compared between the subgroups. The comparison results were listed in Table 5, which showed that patients who were >70 years old had significantly more leucopenia and neutropenia cases (both P < 0.05), and that more leucopenia cases were observed in IV-stage patients compared to IIIB-stage patients (P < 0.05). However, no relationship between other clinical features, including smoking history and gender, with the adverse reactions was found in this analysis (all P > 0.05).

Table 5

Association of reverse reactions with clinical data in the treatment group

Parameters Age (years) Gender Smoking TNM stage
≤70 >70 Female Male Never Ever IIIB IV
Leucopenia 3 10 3 10 4 9 0 13
P value 0.007* 0.787 0.417 0.042*
Neutropenia 2 8 2 8 3 7 1 9
P value 0.025* 0.606 0.606 1.000
Haemoglobinia 4 5 2 7 2 7 0 9
P value 0.964 0.795 0.795 0.178
Thrombocytopenia 0 1 0 1 0 1 0 1
P value 0.353 0.554 0.554 0.732
Increased ALT 1 2 1 2 0 3 0 3
P value 0.660 0.718 0.278 0.531
Increased AST 0 3 1 2 1 2 1 2
P value 0.089 0.718 0.718 0.144
Nausea 1 3 1 3 1 3 0 4
P value 0.369 1.000 1.000 0.456
Emesis 1 3 2 2 1 3 1 3
P value 0.369 0.197 1.000 0.264
ST-T changes 0 1 0 1 0 1 0 1
P value 0.353 0.554 0.554 0.732
Blood pressure fluctuation 0 2 1 1 0 2 0 2
P value 0.178 0.389 0.389 0.619

*P < 0.05.

4 Discussion

In malignant tumors, intratumoral injection of chemotherapeutic drugs combined with cryotherapy and hyperthermia is a good cooperative therapeutic strategy for disease treatment [20]. A study by Weill et al. reported the data from 12 lung cancer patients (six LSCC cases and six lung adenocarcinoma cases) who underwent intratumoral injection of recombinant human p53 adenovirus under bronchoscopy, which found that the airway obstruction of 50% patients was relieved, and three cases in the 12 patients were partially relieved [21]. Local injection through the bronchoscope can obviously increase drug concentration in tumors and is characterized by a small drug dosage and obviously reduced adverse reactions [22]. Due to the high local drug concentration in tumors and long drug action time, tumors shrink rapidly, and thereby the airway obstruction and ventilation were significantly relieved, improving the quality of life and prolonging survival in lung cancer patients. Currently, the commonly used drugs for intracavitary injection include chemotherapy drugs (cisplatin, mitomycin, and epirubicin), absolute ethanol, interleukin-2 (IL-2), and gene-based drugs (recombinant human p53 adenovirus injection), but the drugs above are still in the exploratory stage [23]. This study aimed to investigate the combined injection of endostar and cisplatin with the hope to provide novel ideas for the therapy of LSCC.

Cisplatin is a kind of non-specific cytotoxic drug and plays a pivotal role in the treatment of lung cancer [24]. As we all know, cisplatin is a dose-dependent drug, meaning that the higher the concentration, the greater the killing effect on tumor cells. However, high doses of cisplatin cause serious adverse reactions, leading to its limited clinical application [25]. Previous reports have confirmed that after the body cavity injection of cisplatin, the peak concentration and concentration-time curve area in the cavity were 20 times and 12 times that in the plasma, respectively, which improved the effect of chemotherapy [26]. At the same time, about 60% of the intracavitary drugs can be absorbed into the systemic circulation and re-enter the tumor tissue to kill tumor cells [27]. Thus, there are many basic and clinical trials that have used an intracavitary infusion of cisplatin to treat malignant pleural effusion and pericardial effusion, and good results have been achieved [28,29]. Therefore, local tumor injection of cisplatin should also be able to achieve the purpose of efficient killing of tumor cells and effectively reduce the toxic and side effects of systemic medication. This corollary has been confirmed in several studies, which provided evidence for intratumoral injection of cisplatin [30,31].

Endostar with its full name of recombinant human endostatin injection is the first endostatin-based new drug for lung cancer. It has a significant biological function, including tumor neovascularization inhibition and promotion of cancer cell apoptosis. As our innovation, this study added endostar to the local injection of cisplatin. There is no indication of local use of endostar in the instructions till now, and the relevant study to observe the dosage of local use of endostar was also rare. In order to provide more ideas for the treatment of LSCC, we chose the intratumoral injection method of cisplatin combined with endostar. Through our observation, we found that the intratumoral injection of cisplatin and endostar under bronchoscope, especially combined with the freezing and hyperthermia technology, significantly eliminated the tumor in time, controlled the tumor growth, maintained the patency of the tracheal and bronchial lumens, prolonged the time of tracheal restenosis, and had no obvious complications, which is a rapid, effective, and safe interventional treatment method under bronchoscope. Compared to the LSCC patients who underwent conventional chemoradiotherapy, intratumoral injection of endostar and cisplatin had better short- and long-term therapeutic efficacy, which was evidenced by the markedly increased CRR and CBR, and improved PFS in the treatment group.

Endostar has a significant anti-tumor angiogenesis effect and can significantly reduce the expression of vascular endothelial growth factor (VEGF), which has a greater effect on inhibiting tumor infiltration and metastasis [32]. VEGF is a multifunctional cytokine that interacts directly with vascular endothelial cells, exerting a strong vasoactive effect, increasing the permeability of microvessels, and promoting the infiltration and metastasis of tumor cells [15]. Previous studies showed that endostar can directly inhibit the proliferation, migration, and differentiation, promote the apoptosis of vascular endothelial cells, and antagonize the role of VEGF in promoting angiogenesis and increasing vascular permeability [33]. It has the advantages of a broad anti-tumor spectrum, low toxicity, and no drug resistance and plays a synergistic role when combined with cisplatin [34].

Our previous study has reported the improved therapeutic efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in the treatment of malignant central airway obstruction [18]. In the present study, we further assessed the adverse reactions to evaluate the safety of this therapeutic method. In the treatment group of this study, myelosuppression was the major adverse reaction, such as leucopenia, neutropenia, and haemoglobinia. In addition, one ST-T change case and two blood pressure fluctuation patients were observed after the treatment. Considering the causes of the adverse reactions, the myelosuppression, liver dysfunction, and gastrointestinal reactions might be caused by conventional chemotherapy, which is consistent with previous reports [35]. The cardiovascular adverse reactions only showed up in the treatment group, which were considered to be related to the use of endostar, but most of them disappeared within 1–2 weeks after the therapy without any hindrance to the subsequent therapy. Compared with the control group, in which patients only received conventional chemoradiotherapy, the treatment group had no significant differences in adverse reactions, indicating the acceptable safety of bronchoscopic intratumoral injection of endostar and cisplatin for the treatment of LSCC.

To discover the factors that might affect the therapeutic efficacy and adverse reactions of the intratumoral injection method, the patients in the treatment group were further divided into multiple subgroups based on their clinical characteristics. The age and TNM stage were found to be significantly associated with efficacy and the onset of adverse reactions. Compared with younger or early-stage tumor patients, older patients or advanced tumor patients had worse therapeutic efficacy and a higher probability of adverse reactions after endostar and cisplatin injection. These findings are in accordance with the conclusions from previous studies, which reported that age and TNM stage are two important factors related to clinical outcomes in cancer patients [36]. Thus, the monitoring and prevention of adverse reactions should be strengthened in the elderly and advanced LSCC patients after the treatment.

Some limitations were included in this study, and the first and most important was the small sample size. The data from only 20 patients who received a bronchoscopic intratumoral injection of endostar and cisplatin were collected and analyzed. More evidence is necessary for larger cohorts. Second, this study failed to analyze the data from patients who received therapy with different administration methods. Adverse reactions might be reduced by different administration methods. Therefore, further studies are warranted using larger study populations and a variety of dosing methods.

To sum up, this study provides clinical evidence for the application of bronchoscopic intratumoral injection of endostar and cisplatin as an adjuvant therapeutic strategy for the treatment of LSCC. The analysis of the data from 20 LSCC patients indicated that endostar and cisplatin intratumoral injection had better short- and long-term therapeutic efficacy and had no significant additional adverse reactions compared to conventional chemoradiotherapy. Endoscopic injection of endostar may have some cardiovascular adverse reactions, but most of them are transient and reversible and have no obvious effect on the subsequent treatment. In addition, in the clinical practices of endoscopic injection of endostar and cisplatin, it is necessary to consider the age and clinical stage of patients, and dynamic monitoring of the electrocardiogram and clinical symptoms are also needed. However, the small sample size may limit the accuracy of the analysis results. A larger study population may provide some interesting information and indications.

# The first two authors contributed equally to this work.

tel: +86-0532-83776195, fax: +86-0532-83776195

  1. Funding information: This study was funded by the Qingdao 2020 Annual Medical Research Guidance Plan (2020-WJZD041).

  2. Author contributions: YJ, SL and WJ carried out the research design and conception; YJ, SL, XY and BY collected clinical data from all participants; YJ, SL, XJ and HW analyzed and interpreted the data regarding; XY, BY, XJ, HW and WJ performed the treatment regimens; YJ, SL and WJ wrote the manuscript; YJ and SL revised the manuscript. All authors read and approved the final manuscript.

  3. Conflict of interest: The authors declare that they have no competing interest.

  4. Data availability statement: The data of this study are available from the corresponding author upon reasonable request.

References

[1] Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.10.3322/caac.21262Search in Google Scholar PubMed

[2] Jonna S, Subramaniam DS. Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): An update. Discov Med. 2019;27(148):167–70.Search in Google Scholar

[3] Arbour KC, Riely GJ. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: A review. JAMA. 2019;322(8):764–74.10.1001/jama.2019.11058Search in Google Scholar PubMed

[4] Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: Epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc. 2019;94(8):1623–40.10.1016/j.mayocp.2019.01.013Search in Google Scholar PubMed

[5] Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–54.10.1038/nature25183Search in Google Scholar PubMed

[6] Kita K, Fukuda K, Takahashi H, Tanimoto A, Nishiyama A, Arai S, et al. Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance. Cancer Sci. 2019;110(10):3215–24.10.1111/cas.14171Search in Google Scholar PubMed PubMed Central

[7] Folch EE, Labarca G, Ospina-Delgado D, Kheir F, Majid A, Khandhar SJ, et al. Sensitivity and safety of electromagnetic navigation bronchoscopy for lung cancer diagnosis: Systematic review and meta-analysis. Chest. 2020;158(4):1753–69.10.1016/j.chest.2020.05.534Search in Google Scholar PubMed

[8] Hill RC, Ginn PE, Thompson MS, Seguin MA, Miller D, Taylor DP. Endobronchial polyp derived from a myxosarcoma in the lung of a dog. J Am Anim Hosp Assoc. 2008;44(6):327–34.10.5326/0440327Search in Google Scholar PubMed

[9] Bauer TL, Berkheim DB. Bronchoscopy: Diagnostic and therapeutic for non-small cell lung cancer. Surg Oncol Clin N Am. 2016;25(3):481–91.10.1016/j.soc.2016.02.009Search in Google Scholar PubMed

[10] Kaneko Y, Mouri T, Seto Y, Nishioka N, Yoshimura A, Yamamoto C, et al. The quality of life of patients with suspected lung cancer before and after bronchoscopy and the effect of mirtazapine on the depressive status. Intern Med. 2020;59(13):1605–10.10.2169/internalmedicine.4341-19Search in Google Scholar PubMed PubMed Central

[11] Fournel L, Wu Z, Stadler N, Damotte D, Lococo F, Boulle G, et al. Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer. Cancer Lett. 2019;464:5–14.10.1016/j.canlet.2019.08.005Search in Google Scholar PubMed

[12] Mori V, Roy GS, Bates JHT, Kinsey CM. Cisplatin pharmacodynamics following endobronchial ultrasound-guided transbronchial needle injection into lung tumors. Sci Rep. 2019;9(1):6819.10.1038/s41598-019-43270-ySearch in Google Scholar PubMed PubMed Central

[13] Li K, Shi M, Qin S. Current status and study progress of recombinant human endostatin in cancer treatment. Oncol Ther. 2018;6(1):21–43.10.1007/s40487-017-0055-1Search in Google Scholar PubMed PubMed Central

[14] Shukla NA, Yan MN, Hanna N. The story of angiogenesis inhibitors in non-small-cell lung cancer: The past, present, and future. Clin Lung Cancer. 2020;21(4):308–13.10.1016/j.cllc.2020.02.024Search in Google Scholar PubMed

[15] Frezzetti D, Gallo M, Maiello MR, D’Alessio A, Esposito C, Chicchinelli N, et al. VEGF as a potential target in lung cancer. Expert Opin Ther Targets. 2017;21(10):959–66.10.1080/14728222.2017.1371137Search in Google Scholar PubMed

[16] Guan L. Endostar rebuilding vascular homeostasis and enhancing chemotherapy efficacy in cervical cancer treatment. Onco Targets Ther. 2020;13:12811–27.10.2147/OTT.S277644Search in Google Scholar PubMed PubMed Central

[17] Guo F, Chen C, Liang Y, Ma S, Zou W. Efficacy of the combination of endostar with chemotherapy on stage IVb and recurrent metastatic cervical cancer. Zhong Nan Da Xue Bao Yi Xue Ban. 2020;45(12):1412–8.Search in Google Scholar

[18] Jiang W, Yang X, Wang X, Li Y, Yang X, Wang N, et al. Bronchoscopic intratumoral injections of cisplatin and endostar as concomitants of standard chemotherapy to treat malignant central airway obstruction. Postgrad Med J. 2020;98(1156):104–12.10.1136/postgradmedj-2020-138823Search in Google Scholar PubMed

[19] Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92(3):205–16.10.1093/jnci/92.3.205Search in Google Scholar PubMed

[20] Celikoglu F, Celikoglu SI, Goldberg EP. Bronchoscopic intratumoral chemotherapy of lung cancer. Lung Cancer. 2008;61(1):1–12.10.1016/j.lungcan.2008.03.009Search in Google Scholar PubMed

[21] Weill D, Mack M, Roth J, Swisher S, Proksch S, Merritt J, et al. Adenoviral-mediated p53 gene transfer to non-small cell lung cancer through endobronchial injection. Chest. 2000;118(4):966–70.10.1378/chest.118.4.966Search in Google Scholar PubMed

[22] DeMaio A, Sterman D. Bronchoscopic intratumoural therapies for non-small cell lung cancer. Eur Respir Rev. 2020;29(156):200028.10.1183/16000617.0028-2020Search in Google Scholar PubMed PubMed Central

[23] Yang L, Wang B, Qiao W, Liu P. A novel combination chemotherapy integrating with intratumoral chemotherapy. Med Hypotheses. 2009;73(3):334–5.10.1016/j.mehy.2009.04.002Search in Google Scholar PubMed

[24] Teng JP, Yang ZY, Zhu YM, Ni D, Zhu ZJ, Li XQ. Gemcitabine and cisplatin for treatment of lung cancer in vitro and vivo. Eur Rev Med Pharmacol Sci. 2018;22(12):3819–25.Search in Google Scholar

[25] Bright HR, Chandy SJ, Chacko RT, Backianathan S. Intercycle unplanned hospital admissions due to cisplatin-based chemotherapy regimen-induced adverse reactions: A retrospective analysis. Curr Drug Saf. 2019;14(3):182–91.10.2174/1574886314666190619123047Search in Google Scholar PubMed PubMed Central

[26] Ghosh S. Cisplatin: The first metal based anticancer drug. Bioorg Chem. 2019;88:102925.10.1016/j.bioorg.2019.102925Search in Google Scholar PubMed

[27] Gao L, Cai S, Cai A, Zhao Y, Xu T, Ma Y, et al. The improved antitumor efficacy of continuous intratumoral chemotherapy with cisplatin-loaded implants for the treatment of sarcoma 180 tumor-bearing mice. Drug Deliv. 2019;26(1):208–15.10.1080/10717544.2019.1574938Search in Google Scholar PubMed PubMed Central

[28] Zhou Z, Li H, Hu D, Xie L. Clinical efficacy of bevacizumab combined with cisplatin in the treatment of malignant pleural effusion and ascites caused by lung cancer: a randomized trial. Ann Palliat Med. 2021;10(10):10575–83.10.21037/apm-21-2623Search in Google Scholar PubMed

[29] Luo P, Cao P, Yao Z. Efficacy of radiofrequency hyperthermia combined with chemotherapy in treatment of malignant pericardial effusion caused by lung cancer. Zhongguo Fei Ai Za Zhi. 2011;14(7):593–7.Search in Google Scholar

[30] Tabatabaei P, Asklund T, Bergstrom P, Bjorn E, Johansson M, Bergenheim AT. Intratumoral retrograde microdialysis treatment of high-grade glioma with cisplatin. Acta Neurochir (Wien). 2020;162(12):3043–53.10.1007/s00701-020-04488-2Search in Google Scholar PubMed

[31] Lee SY, Kang TH, Knoff J, Huang Z, Soong RS, Alvarez RD, et al. Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects. Cancer Immunol Immunother. 2013;62(7):1175–85.10.1007/s00262-013-1421-ySearch in Google Scholar PubMed PubMed Central

[32] Wu J, Zhao X, Sun Q, Jiang Y, Zhang W, Luo J, et al. Synergic effect of PD-1 blockade and endostar on the PI3K/AKT/mTOR-mediated autophagy and angiogenesis in Lewis lung carcinoma mouse model. Biomed Pharmacother. 2020;125:109746.10.1016/j.biopha.2019.109746Search in Google Scholar PubMed

[33] Feng G, Lei Z, Wang D, Xu N, Wei Q, Li D, et al. The evaluation of anti-angiogenic effects of Endostar on rabbit VX2 portal vein tumor thrombus using perfusion MSCT. Cancer Imaging. 2014;14:17.10.1186/1470-7330-14-17Search in Google Scholar PubMed PubMed Central

[34] Peng L, Wang Y, Fei S, Wei C, Tong F, Wu G, et al. The effect of combining Endostar with radiotherapy on blood vessels, tumor-associated macrophages, and T cells in brain metastases of Lewis lung cancer. Transl Lung Cancer Res. 2020;9(3):745–60.10.21037/tlcr-20-500Search in Google Scholar PubMed PubMed Central

[35] Wang Y, Zhang R, Shen Y, Su L, Dong B, Hao Q. Prediction of chemotherapy adverse reactions and mortality in older patients with primary lung cancer through frailty index based on routine laboratory data. Clin Interv Aging. 2019;14:1187–97.10.2147/CIA.S201873Search in Google Scholar PubMed PubMed Central

[36] Woodard GA, Jones KD, Jablons DM. Lung cancer staging and prognosis. Cancer Treat Res. 2016;170:47–75.10.1007/978-3-319-40389-2_3Search in Google Scholar PubMed

Received: 2022-03-29
Revised: 2022-11-20
Accepted: 2022-12-22
Published Online: 2023-04-03

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. Exosomes derived from mesenchymal stem cells overexpressing miR-210 inhibits neuronal inflammation and contribute to neurite outgrowth through modulating microglia polarization
  3. Current situation of acute ST-segment elevation myocardial infarction in a county hospital chest pain center during an epidemic of novel coronavirus pneumonia
  4. circ-IARS depletion inhibits the progression of non-small-cell lung cancer by circ-IARS/miR-1252-5p/HDGF ceRNA pathway
  5. circRNA ITGA7 restrains growth and enhances radiosensitivity by up-regulating SMAD4 in colorectal carcinoma
  6. WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4
  7. Up-regulation of collagen type V alpha 2 (COL5A2) promotes malignant phenotypes in gastric cancer cell via inducing epithelial–mesenchymal transition (EMT)
  8. Inhibition of TERC inhibits neural apoptosis and inflammation in spinal cord injury through Akt activation and p-38 inhibition via the miR-34a-5p/XBP-1 axis
  9. 3D-printed polyether-ether-ketone/n-TiO2 composite enhances the cytocompatibility and osteogenic differentiation of MC3T3-E1 cells by downregulating miR-154-5p
  10. Propofol-mediated circ_0000735 downregulation restrains tumor growth by decreasing integrin-β1 expression in non-small cell lung cancer
  11. PVT1/miR-16/CCND1 axis regulates gastric cancer progression
  12. Silencing of circ_002136 sensitizes gastric cancer to paclitaxel by targeting the miR-16-5p/HMGA1 axis
  13. Short-term outcomes after simultaneous gastrectomy plus cholecystectomy in gastric cancer: A pooling up analysis
  14. SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways
  15. Molecular mechanism by which the Notch signaling pathway regulates autophagy in a rat model of pulmonary fibrosis in pigeon breeder’s lung
  16. lncRNA TPT1-AS1 promotes cell migration and invasion in esophageal squamous-cell carcinomas by regulating the miR-26a/HMGA1 axis
  17. SIRT1/APE1 promotes the viability of gastric cancer cells by inhibiting p53 to suppress ferroptosis
  18. Glycoprotein non-metastatic melanoma B interacts with epidermal growth factor receptor to regulate neural stem cell survival and differentiation
  19. Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
  20. Association of osteoporosis and skeletal muscle loss with serum type I collagen carboxyl-terminal peptide β glypeptide: A cross-sectional study in elder Chinese population
  21. circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathway
  22. Delivery in a vertical birth chair supported by freedom of movement during labor: A randomized control trial
  23. UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K/AKT and MDM2/p53 signaling
  24. Metabolic resuscitation therapy in critically ill patients with sepsis and septic shock: A pilot prospective randomized controlled trial
  25. Lycopene ameliorates locomotor activity and urinary frequency induced by pelvic venous congestion in rats
  26. UHRF1-induced connexin26 methylation is involved in hearing damage triggered by intermittent hypoxia in neonatal rats
  27. LINC00511 promotes melanoma progression by targeting miR-610/NUCB2
  28. Ultra-high-performance liquid chromatography-tandem mass spectrometry analysis of serum metabolomic characteristics in people with different vitamin D levels
  29. Role of Jumonji domain-containing protein D3 and its inhibitor GSK-J4 in Hashimoto’s thyroiditis
  30. circ_0014736 induces GPR4 to regulate the biological behaviors of human placental trophoblast cells through miR-942-5p in preeclampsia
  31. Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies
  32. Effects of osteogenic growth peptide C-terminal pentapeptide and its analogue on bone remodeling in an osteoporosis rat model
  33. A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma
  34. WGCNA-based identification of potential targets and pathways in response to treatment in locally advanced breast cancer patients
  35. Radiomics model using preoperative computed tomography angiography images to differentiate new from old emboli of acute lower limb arterial embolism
  36. Dysregulated lncRNAs are involved in the progress of myocardial infarction by constructing regulatory networks
  37. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy
  38. Genetic polymorphisms of MRPS30-DT and NINJ2 may influence lung cancer risk
  39. Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis
  40. Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma
  41. Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
  42. CircRANBP17 modulated KDM1A to regulate neuroblastoma progression by sponging miR-27b-3p
  43. Exosomal miR-93-5p regulated the progression of osteoarthritis by targeting ADAMTS9
  44. Downregulation of RBM17 enhances cisplatin sensitivity and inhibits cell invasion in human hypopharyngeal cancer cells
  45. HDAC5-mediated PRAME regulates the proliferation, migration, invasion, and EMT of laryngeal squamous cell carcinoma via the PI3K/AKT/mTOR signaling pathway
  46. The association between sleep duration, quality, and nonalcoholic fatty liver disease: A cross-sectional study
  47. Myostatin silencing inhibits podocyte apoptosis in membranous nephropathy through Smad3/PKA/NOX4 signaling pathway
  48. A novel long noncoding RNA AC125257.1 facilitates colorectal cancer progression by targeting miR-133a-3p/CASC5 axis
  49. Impact of omicron wave and associated control measures in Shanghai on health management and psychosocial well-being of patients with chronic conditions
  50. Clinicopathological characteristics and prognosis of young patients aged ≤45 years old with non-small cell lung cancer
  51. TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia
  52. The dose limits of teeth protection for patients with nasopharyngeal carcinoma undergoing radiotherapy based on the early oral health-related quality of life
  53. miR-30b-5p targeting GRIN2A inhibits hippocampal damage in epilepsy
  54. Long non-coding RNA AL137789.1 promoted malignant biological behaviors and immune escape of pancreatic carcinoma cells
  55. IRF6 and FGF1 polymorphisms in non-syndromic cleft lip with or without cleft palate in the Polish population
  56. Comprehensive analysis of the role of SFXN family in breast cancer
  57. Efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in lung squamous cell carcinoma patients underwent conventional chemoradiotherapy
  58. Silencing of long noncoding RNA MIAT inhibits the viability and proliferation of breast cancer cells by promoting miR-378a-5p expression
  59. AG1024, an IGF-1 receptor inhibitor, ameliorates renal injury in rats with diabetic nephropathy via the SOCS/JAK2/STAT pathway
  60. Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition
  61. Exendin-4 regulates the MAPK and WNT signaling pathways to alleviate the osteogenic inhibition of periodontal ligament stem cells in a high glucose environment
  62. Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3
  63. The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma
  64. Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
  65. Ultrasound examination supporting CT or MRI in the evaluation of cervical lymphadenopathy in patients with irradiation-treated head and neck cancer
  66. F-box and WD repeat domain containing 7 inhibits the activation of hepatic stellate cells by degrading delta-like ligand 1 to block Notch signaling pathway
  67. Knockdown of circ_0005615 enhances the radiosensitivity of colorectal cancer by regulating the miR-665/NOTCH1 axis
  68. Long noncoding RNA Mhrt alleviates angiotensin II-induced cardiac hypertrophy phenotypes by mediating the miR-765/Wnt family member 7B pathway
  69. Effect of miR-499-5p/SOX6 axis on atrial fibrosis in rats with atrial fibrillation
  70. Cholesterol induces inflammation and reduces glucose utilization
  71. circ_0004904 regulates the trophoblast cell in preeclampsia via miR-19b-3p/ARRDC3 axis
  72. NECAB3 promotes the migration and invasion of liver cancer cells through HIF-1α/RIT1 signaling pathway
  73. The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
  74. miR-2053 inhibits the growth of ovarian cancer cells by downregulating SOX4
  75. Nucleophosmin 1 associating with engulfment and cell motility protein 1 regulates hepatocellular carcinoma cell chemotaxis and metastasis
  76. α-Hederin regulates macrophage polarization to relieve sepsis-induced lung and liver injuries in mice
  77. Changes of microbiota level in urinary tract infections: A meta-analysis
  78. Identification of key enzalutamide-resistance-related genes in castration-resistant prostate cancer and verification of RAD51 functions
  79. Falls during oxaliplatin-based chemotherapy for gastrointestinal malignancies – (lessons learned from) a prospective study
  80. Outcomes of low-risk birth care during the Covid-19 pandemic: A cohort study from a tertiary care center in Lithuania
  81. Vitamin D protects intestines from liver cirrhosis-induced inflammation and oxidative stress by inhibiting the TLR4/MyD88/NF-κB signaling pathway
  82. Integrated transcriptome analysis identifies APPL1/RPS6KB2/GALK1 as immune-related metastasis factors in breast cancer
  83. Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
  84. Circular RNA Circ_0038467 promotes the maturation of miRNA-203 to increase lipopolysaccharide-induced apoptosis of chondrocytes
  85. An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy
  86. Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
  87. Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
  88. PTPN12 down-regulated by miR-146b-3p gene affects the malignant progression of laryngeal squamous cell carcinoma
  89. miR-141-3p accelerates ovarian cancer progression and promotes M2-like macrophage polarization by targeting the Keap1-Nrf2 pathway
  90. lncRNA OIP5-AS1 attenuates the osteoarthritis progression in IL-1β-stimulated chondrocytes
  91. Overexpression of LINC00607 inhibits cell growth and aggressiveness by regulating the miR-1289/EFNA5 axis in non-small-cell lung cancer
  92. Subjective well-being in informal caregivers during the COVID-19 pandemic
  93. Nrf2 protects against myocardial ischemia-reperfusion injury in diabetic rats by inhibiting Drp1-mediated mitochondrial fission
  94. Unfolded protein response inhibits KAT2B/MLKL-mediated necroptosis of hepatocytes by promoting BMI1 level to ubiquitinate KAT2B
  95. Bladder cancer screening: The new selection and prediction model
  96. circNFATC3 facilitated the progression of oral squamous cell carcinoma via the miR-520h/LDHA axis
  97. Prone position effect in intensive care patients with SARS-COV-2 pneumonia
  98. Clinical observation on the efficacy of Tongdu Tuina manipulation in the treatment of primary enuresis in children
  99. Dihydroartemisinin ameliorates cerebral I/R injury in rats via regulating VWF and autophagy-mediated SIRT1/FOXO1 pathway
  100. Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway
  101. Low Ang-(1–7) and high des-Arg9 bradykinin serum levels are correlated with cardiovascular risk factors in patients with COVID-19
  102. Effect of maternal age and body mass index on induction of labor with oral misoprostol for premature rupture of membrane at term: A retrospective cross-sectional study
  103. Potential protective effects of Huanglian Jiedu Decoction against COVID-19-associated acute kidney injury: A network-based pharmacological and molecular docking study
  104. Clinical significance of serum MBD3 detection in girls with central precocious puberty
  105. Clinical features of varicella-zoster virus caused neurological diseases detected by metagenomic next-generation sequencing
  106. Collagen treatment of complex anorectal fistula: 3 years follow-up
  107. LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through down-regulating SP-A by sponging to miR-424
  108. Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen – An open-label, randomized trial
  109. SMOC2 plays a role in heart failure via regulating TGF-β1/Smad3 pathway-mediated autophagy
  110. A prospective cohort study of the impact of chronic disease on fall injuries in middle-aged and older adults
  111. circRNA THBS1 silencing inhibits the malignant biological behavior of cervical cancer cells via the regulation of miR-543/HMGB2 axis
  112. hsa_circ_0000285 sponging miR-582-3p promotes neuroblastoma progression by regulating the Wnt/β-catenin signaling pathway
  113. Long non-coding RNA GNAS-AS1 knockdown inhibits proliferation and epithelial–mesenchymal transition of lung adenocarcinoma cells via the microRNA-433-3p/Rab3A axis
  114. lncRNA UCA1 regulates miR-132/Lrrfip1 axis to promote vascular smooth muscle cell proliferation
  115. Twenty-four-color full spectrum flow cytometry panel for minimal residual disease detection in acute myeloid leukemia
  116. Hsa-miR-223-3p participates in the process of anthracycline-induced cardiomyocyte damage by regulating NFIA gene
  117. Anti-inflammatory effect of ApoE23 on Salmonella typhimurium-induced sepsis in mice
  118. Analysis of somatic mutations and key driving factors of cervical cancer progression
  119. Hsa_circ_0028007 regulates the progression of nasopharyngeal carcinoma through the miR-1179/SQLE axis
  120. Variations in sexual function after laparoendoscopic single-site hysterectomy in women with benign gynecologic diseases
  121. Effects of pharmacological delay with roxadustat on multi-territory perforator flap survival in rats
  122. Analysis of heroin effects on calcium channels in rat cardiomyocytes based on transcriptomics and metabolomics
  123. Risk factors of recurrent bacterial vaginosis among women of reproductive age: A cross-sectional study
  124. Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells
  125. Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients
  126. Correlation between microvessel maturity and ISUP grades assessed using contrast-enhanced transrectal ultrasonography in prostate cancer
  127. The protective effect of caffeic acid phenethyl ester in the nephrotoxicity induced by α-cypermethrin
  128. Norepinephrine alleviates cyclosporin A-induced nephrotoxicity by enhancing the expression of SFRP1
  129. Effect of RUNX1/FOXP3 axis on apoptosis of T and B lymphocytes and immunosuppression in sepsis
  130. The function of Foxp1 represses β-adrenergic receptor transcription in the occurrence and development of bladder cancer through STAT3 activity
  131. Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU
  132. Calycosin protects against chronic prostatitis in rats via inhibition of the p38MAPK/NF-κB pathway
  133. Pan-cancer analysis of the PDE4DIP gene with potential prognostic and immunotherapeutic values in multiple cancers including acute myeloid leukemia
  134. The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
  135. Circ-UBR4 regulates the proliferation, migration, inflammation, and apoptosis in ox-LDL-induced vascular smooth muscle cells via miR-515-5p/IGF2 axis
  136. Clinical characteristics of current COVID-19 rehabilitation outpatients in China
  137. Luteolin alleviates ulcerative colitis in rats via regulating immune response, oxidative stress, and metabolic profiling
  138. miR-199a-5p inhibits aortic valve calcification by targeting ATF6 and GRP78 in valve interstitial cells
  139. The application of iliac fascia space block combined with esketamine intravenous general anesthesia in PFNA surgery of the elderly: A prospective, single-center, controlled trial
  140. Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
  141. The effects of progesterone on the healing of obstetric anal sphincter damage in female rats
  142. Identification of cuproptosis-related genes for predicting the development of prostate cancer
  143. Lumican silencing ameliorates β-glycerophosphate-mediated vascular smooth muscle cell calcification by attenuating the inhibition of APOB on KIF2C activity
  144. Targeting PTBP1 blocks glutamine metabolism to improve the cisplatin sensitivity of hepatocarcinoma cells through modulating the mRNA stability of glutaminase
  145. A single center prospective study: Influences of different hip flexion angles on the measurement of lumbar spine bone mineral density by dual energy X-ray absorptiometry
  146. Clinical analysis of AN69ST membrane continuous venous hemofiltration in the treatment of severe sepsis
  147. Antibiotics therapy combined with probiotics administered intravaginally for the treatment of bacterial vaginosis: A systematic review and meta-analysis
  148. Construction of a ceRNA network to reveal a vascular invasion associated prognostic model in hepatocellular carcinoma
  149. A pan-cancer analysis of STAT3 expression and genetic alterations in human tumors
  150. A prognostic signature based on seven T-cell-related cell clustering genes in bladder urothelial carcinoma
  151. Pepsin concentration in oral lavage fluid of rabbit reflux model constructed by dilating the lower esophageal sphincter
  152. The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
  153. Tanshinone IIA attenuates valvular interstitial cells’ calcification induced by oxidized low density lipoprotein via reducing endoplasmic reticulum stress
  154. AS-IV enhances the antitumor effects of propofol in NSCLC cells by inhibiting autophagy
  155. Establishment of two oxaliplatin-resistant gallbladder cancer cell lines and comprehensive analysis of dysregulated genes
  156. Trial protocol: Feasibility of neuromodulation with connectivity-guided intermittent theta-burst stimulation for improving cognition in multiple sclerosis
  157. LncRNA LINC00592 mediates the promoter methylation of WIF1 to promote the development of bladder cancer
  158. Factors associated with gastrointestinal dysmotility in critically ill patients
  159. Mechanisms by which spinal cord stimulation intervenes in atrial fibrillation: The involvement of the endothelin-1 and nerve growth factor/p75NTR pathways
  160. Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics
  161. Silencing USP19 alleviates cigarette smoke extract-induced mitochondrial dysfunction in BEAS-2B cells by targeting FUNDC1
  162. Menstrual irregularities associated with COVID-19 vaccines among women in Saudi Arabia: A survey during 2022
  163. Ferroptosis involves in Schwann cell death in diabetic peripheral neuropathy
  164. The effect of AQP4 on tau protein aggregation in neurodegeneration and persistent neuroinflammation after cerebral microinfarcts
  165. Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
  166. Analysis of clinical characteristics in proximal and distal reflux monitoring among patients with gastroesophageal reflux disease
  167. Exosomal circ-0020887 and circ-0009590 as novel biomarkers for the diagnosis and prediction of short-term adverse cardiovascular outcomes in STEMI patients
  168. Upregulated microRNA-429 confers endometrial stromal cell dysfunction by targeting HIF1AN and regulating the HIF1A/VEGF pathway
  169. Bibliometrics and knowledge map analysis of ultrasound-guided regional anesthesia
  170. Knockdown of NUPR1 inhibits angiogenesis in lung cancer through IRE1/XBP1 and PERK/eIF2α/ATF4 signaling pathways
  171. D-dimer trends predict COVID-19 patient’s prognosis: A retrospective chart review study
  172. WTAP affects intracranial aneurysm progression by regulating m6A methylation modification
  173. Using of endoscopic polypectomy in patients with diagnosed malignant colorectal polyp – The cross-sectional clinical study
  174. Anti-S100A4 antibody administration alleviates bronchial epithelial–mesenchymal transition in asthmatic mice
  175. Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma
  176. Prevalence and antibiogram of bacteria causing urinary tract infection among patients with chronic kidney disease
  177. Reactive oxygen species within the vaginal space: An additional promoter of cervical intraepithelial neoplasia and uterine cervical cancer development?
  178. Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma
  179. A new technique for uterine-preserving pelvic organ prolapse surgery: Laparoscopic rectus abdominis hysteropexy for uterine prolapse by comparing with traditional techniques
  180. Self-isolation of an Italian long-term care facility during COVID-19 pandemic: A comparison study on care-related infectious episodes
  181. A comparative study on the overlapping effects of clinically applicable therapeutic interventions in patients with central nervous system damage
  182. Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome: Long-term follow-up
  183. The diagnostic accuracy of touch imprint cytology for sentinel lymph node metastases of breast cancer: An up-to-date meta-analysis of 4,073 patients
  184. Mortality associated with Sjögren’s syndrome in the United States in the 1999–2020 period: A multiple cause-of-death study
  185. CircMMP11 as a prognostic biomarker mediates miR-361-3p/HMGB1 axis to accelerate malignant progression of hepatocellular carcinoma
  186. Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations
  187. KMT2A maintains stemness of gastric cancer cells through regulating Wnt/β-catenin signaling-activated transcriptional factor KLF11
  188. Evaluation of placental oxygenation by near-infrared spectroscopy in relation to ultrasound maturation grade in physiological term pregnancies
  189. The role of ultrasonographic findings for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer
  190. Construction of immunogenic cell death-related molecular subtypes and prognostic signature in colorectal cancer
  191. Long-term prognostic value of high-sensitivity cardiac troponin-I in patients with idiopathic dilated cardiomyopathy
  192. Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients
  193. Integrative bioinformatics analysis reveals STAT2 as a novel biomarker of inflammation-related cardiac dysfunction in atrial fibrillation
  194. Adipose-derived stem cells repair radiation-induced chronic lung injury via inhibiting TGF-β1/Smad 3 signaling pathway
  195. Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000–2016 cohort
  196. lncRNA LENGA sponges miR-378 to promote myocardial fibrosis in atrial fibrillation
  197. Diagnostic value of urinary Tamm-Horsfall protein and 24 h urine osmolality for recurrent calcium oxalate stones of the upper urinary tract: Cross-sectional study
  198. The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer
  199. The spike protein of SARS-CoV-2 induces inflammation and EMT of lung epithelial cells and fibroblasts through the upregulation of GADD45A
  200. Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
  201. MiR-1278 targets CALD1 and suppresses the progression of gastric cancer via the MAPK pathway
  202. Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson’s disease after dietary supplementation with branched-chain amino acids
  203. Cimifugin inhibits adipogenesis and TNF-α-induced insulin resistance in 3T3-L1 cells
  204. Predictors of gastrointestinal complaints in patients on metformin therapy
  205. Prescribing patterns in patients with chronic obstructive pulmonary disease and atrial fibrillation
  206. A retrospective analysis of the effect of latent tuberculosis infection on clinical pregnancy outcomes of in vitro fertilization–fresh embryo transferred in infertile women
  207. Appropriateness and clinical outcomes of short sustained low-efficiency dialysis: A national experience
  208. miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD
  209. Clinical features and management of lymphoepithelial cyst
  210. Serum VEGF, high-sensitivity CRP, and cystatin-C assist in the diagnosis of type 2 diabetic retinopathy complicated with hyperuricemia
  211. ENPP1 ameliorates vascular calcification via inhibiting the osteogenic transformation of VSMCs and generating PPi
  212. Significance of monitoring the levels of thyroid hormone antibodies and glucose and lipid metabolism antibodies in patients suffer from type 2 diabetes
  213. The causal relationship between immune cells and different kidney diseases: A Mendelian randomization study
  214. Interleukin 33, soluble suppression of tumorigenicity 2, interleukin 27, and galectin 3 as predictors for outcome in patients admitted to intensive care units
  215. Identification of diagnostic immune-related gene biomarkers for predicting heart failure after acute myocardial infarction
  216. Long-term administration of probiotics prevents gastrointestinal mucosal barrier dysfunction in septic mice partly by upregulating the 5-HT degradation pathway
  217. miR-192 inhibits the activation of hepatic stellate cells by targeting Rictor
  218. Diagnostic and prognostic value of MR-pro ADM, procalcitonin, and copeptin in sepsis
  219. Review Articles
  220. Prenatal diagnosis of fetal defects and its implications on the delivery mode
  221. Electromagnetic fields exposure on fetal and childhood abnormalities: Systematic review and meta-analysis
  222. Characteristics of antibiotic resistance mechanisms and genes of Klebsiella pneumoniae
  223. Saddle pulmonary embolism in the setting of COVID-19 infection: A systematic review of case reports and case series
  224. Vitamin C and epigenetics: A short physiological overview
  225. Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients
  226. Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
  227. Mechanism of rhubarb in the treatment of hyperlipidemia: A recent review
  228. Surgical management and outcomes of traumatic global brachial plexus injury: A concise review and our center approach
  229. The progress of autoimmune hepatitis research and future challenges
  230. METTL16 in human diseases: What should we do next?
  231. New insights into the prevention of ureteral stents encrustation
  232. VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature
  233. Case Reports
  234. Mycobacterium xenopi infection of the kidney and lymph nodes: A case report
  235. Genetic mutation of SLC6A20 (c.1072T > C) in a family with nephrolithiasis: A case report
  236. Chronic hepatitis B complicated with secondary hemochromatosis was cured clinically: A case report
  237. Liver abscess complicated with multiple organ invasive infection caused by hematogenous disseminated hypervirulent Klebsiella pneumoniae: A case report
  238. Urokinase-based lock solutions for catheter salvage: A case of an upcoming kidney transplant recipient
  239. Two case reports of maturity-onset diabetes of the young type 3 caused by the hepatocyte nuclear factor 1α gene mutation
  240. Immune checkpoint inhibitor-related pancreatitis: What is known and what is not
  241. Does total hip arthroplasty result in intercostal nerve injury? A case report and literature review
  242. Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi – Case report and literature review
  243. Synchronous triple primary gastrointestinal malignant tumors treated with laparoscopic surgery: A case report
  244. CT-guided percutaneous microwave ablation combined with bone cement injection for the treatment of transverse metastases: A case report
  245. Malignant hyperthermia: Report on a successful rescue of a case with the highest temperature of 44.2°C
  246. Anesthetic management of fetal pulmonary valvuloplasty: A case report
  247. Rapid Communication
  248. Impact of COVID-19 lockdown on glycemic levels during pregnancy: A retrospective analysis
  249. Erratum
  250. Erratum to “Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway”
  251. Erratum to: “Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p”
  252. Retraction
  253. Retraction of “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients”
  254. Retraction of “circ_0062491 alleviates periodontitis via the miR-142-5p/IGF1 axis”
  255. Retraction of “miR-223-3p alleviates TGF-β-induced epithelial-mesenchymal transition and extracellular matrix deposition by targeting SP3 in endometrial epithelial cells”
  256. Retraction of “SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis”
  257. Retraction of “circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury”
  258. Retraction of “lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells”
  259. Special issue Linking Pathobiological Mechanisms to Clinical Application for cardiovascular diseases
  260. Effect of cardiac rehabilitation therapy on depressed patients with cardiac insufficiency after cardiac surgery
  261. Special issue The evolving saga of RNAs from bench to bedside - Part I
  262. FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma
  263. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part III
  264. Development of a machine learning-based signature utilizing inflammatory response genes for predicting prognosis and immune microenvironment in ovarian cancer
https://doi.org/10.1515/med-2023-0640
Keywords for this article
lung squamous cell carcinoma; bronchoscopy; endostar; cisplatin; efficacy; adverse reactions
Creative Commons
BY 4.0

Articles in the same Issue

  1. Research Articles
  2. Exosomes derived from mesenchymal stem cells overexpressing miR-210 inhibits neuronal inflammation and contribute to neurite outgrowth through modulating microglia polarization
  3. Current situation of acute ST-segment elevation myocardial infarction in a county hospital chest pain center during an epidemic of novel coronavirus pneumonia
  4. circ-IARS depletion inhibits the progression of non-small-cell lung cancer by circ-IARS/miR-1252-5p/HDGF ceRNA pathway
  5. circRNA ITGA7 restrains growth and enhances radiosensitivity by up-regulating SMAD4 in colorectal carcinoma
  6. WDR79 promotes aerobic glycolysis of pancreatic ductal adenocarcinoma (PDAC) by the suppression of SIRT4
  7. Up-regulation of collagen type V alpha 2 (COL5A2) promotes malignant phenotypes in gastric cancer cell via inducing epithelial–mesenchymal transition (EMT)
  8. Inhibition of TERC inhibits neural apoptosis and inflammation in spinal cord injury through Akt activation and p-38 inhibition via the miR-34a-5p/XBP-1 axis
  9. 3D-printed polyether-ether-ketone/n-TiO2 composite enhances the cytocompatibility and osteogenic differentiation of MC3T3-E1 cells by downregulating miR-154-5p
  10. Propofol-mediated circ_0000735 downregulation restrains tumor growth by decreasing integrin-β1 expression in non-small cell lung cancer
  11. PVT1/miR-16/CCND1 axis regulates gastric cancer progression
  12. Silencing of circ_002136 sensitizes gastric cancer to paclitaxel by targeting the miR-16-5p/HMGA1 axis
  13. Short-term outcomes after simultaneous gastrectomy plus cholecystectomy in gastric cancer: A pooling up analysis
  14. SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways
  15. Molecular mechanism by which the Notch signaling pathway regulates autophagy in a rat model of pulmonary fibrosis in pigeon breeder’s lung
  16. lncRNA TPT1-AS1 promotes cell migration and invasion in esophageal squamous-cell carcinomas by regulating the miR-26a/HMGA1 axis
  17. SIRT1/APE1 promotes the viability of gastric cancer cells by inhibiting p53 to suppress ferroptosis
  18. Glycoprotein non-metastatic melanoma B interacts with epidermal growth factor receptor to regulate neural stem cell survival and differentiation
  19. Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
  20. Association of osteoporosis and skeletal muscle loss with serum type I collagen carboxyl-terminal peptide β glypeptide: A cross-sectional study in elder Chinese population
  21. circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathway
  22. Delivery in a vertical birth chair supported by freedom of movement during labor: A randomized control trial
  23. UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K/AKT and MDM2/p53 signaling
  24. Metabolic resuscitation therapy in critically ill patients with sepsis and septic shock: A pilot prospective randomized controlled trial
  25. Lycopene ameliorates locomotor activity and urinary frequency induced by pelvic venous congestion in rats
  26. UHRF1-induced connexin26 methylation is involved in hearing damage triggered by intermittent hypoxia in neonatal rats
  27. LINC00511 promotes melanoma progression by targeting miR-610/NUCB2
  28. Ultra-high-performance liquid chromatography-tandem mass spectrometry analysis of serum metabolomic characteristics in people with different vitamin D levels
  29. Role of Jumonji domain-containing protein D3 and its inhibitor GSK-J4 in Hashimoto’s thyroiditis
  30. circ_0014736 induces GPR4 to regulate the biological behaviors of human placental trophoblast cells through miR-942-5p in preeclampsia
  31. Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies
  32. Effects of osteogenic growth peptide C-terminal pentapeptide and its analogue on bone remodeling in an osteoporosis rat model
  33. A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma
  34. WGCNA-based identification of potential targets and pathways in response to treatment in locally advanced breast cancer patients
  35. Radiomics model using preoperative computed tomography angiography images to differentiate new from old emboli of acute lower limb arterial embolism
  36. Dysregulated lncRNAs are involved in the progress of myocardial infarction by constructing regulatory networks
  37. Single-arm trial to evaluate the efficacy and safety of baclofen in treatment of intractable hiccup caused by malignant tumor chemotherapy
  38. Genetic polymorphisms of MRPS30-DT and NINJ2 may influence lung cancer risk
  39. Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis
  40. Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma
  41. Upregulation of lncRNA LANCL1-AS1 inhibits the progression of non-small-cell lung cancer via the miR-3680-3p/GMFG axis
  42. CircRANBP17 modulated KDM1A to regulate neuroblastoma progression by sponging miR-27b-3p
  43. Exosomal miR-93-5p regulated the progression of osteoarthritis by targeting ADAMTS9
  44. Downregulation of RBM17 enhances cisplatin sensitivity and inhibits cell invasion in human hypopharyngeal cancer cells
  45. HDAC5-mediated PRAME regulates the proliferation, migration, invasion, and EMT of laryngeal squamous cell carcinoma via the PI3K/AKT/mTOR signaling pathway
  46. The association between sleep duration, quality, and nonalcoholic fatty liver disease: A cross-sectional study
  47. Myostatin silencing inhibits podocyte apoptosis in membranous nephropathy through Smad3/PKA/NOX4 signaling pathway
  48. A novel long noncoding RNA AC125257.1 facilitates colorectal cancer progression by targeting miR-133a-3p/CASC5 axis
  49. Impact of omicron wave and associated control measures in Shanghai on health management and psychosocial well-being of patients with chronic conditions
  50. Clinicopathological characteristics and prognosis of young patients aged ≤45 years old with non-small cell lung cancer
  51. TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia
  52. The dose limits of teeth protection for patients with nasopharyngeal carcinoma undergoing radiotherapy based on the early oral health-related quality of life
  53. miR-30b-5p targeting GRIN2A inhibits hippocampal damage in epilepsy
  54. Long non-coding RNA AL137789.1 promoted malignant biological behaviors and immune escape of pancreatic carcinoma cells
  55. IRF6 and FGF1 polymorphisms in non-syndromic cleft lip with or without cleft palate in the Polish population
  56. Comprehensive analysis of the role of SFXN family in breast cancer
  57. Efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in lung squamous cell carcinoma patients underwent conventional chemoradiotherapy
  58. Silencing of long noncoding RNA MIAT inhibits the viability and proliferation of breast cancer cells by promoting miR-378a-5p expression
  59. AG1024, an IGF-1 receptor inhibitor, ameliorates renal injury in rats with diabetic nephropathy via the SOCS/JAK2/STAT pathway
  60. Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition
  61. Exendin-4 regulates the MAPK and WNT signaling pathways to alleviate the osteogenic inhibition of periodontal ligament stem cells in a high glucose environment
  62. Inhibition of glycolysis represses the growth and alleviates the endoplasmic reticulum stress of breast cancer cells by regulating TMTC3
  63. The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma
  64. Tectorigenin alleviates the apoptosis and inflammation in spinal cord injury cell model through inhibiting insulin-like growth factor-binding protein 6
  65. Ultrasound examination supporting CT or MRI in the evaluation of cervical lymphadenopathy in patients with irradiation-treated head and neck cancer
  66. F-box and WD repeat domain containing 7 inhibits the activation of hepatic stellate cells by degrading delta-like ligand 1 to block Notch signaling pathway
  67. Knockdown of circ_0005615 enhances the radiosensitivity of colorectal cancer by regulating the miR-665/NOTCH1 axis
  68. Long noncoding RNA Mhrt alleviates angiotensin II-induced cardiac hypertrophy phenotypes by mediating the miR-765/Wnt family member 7B pathway
  69. Effect of miR-499-5p/SOX6 axis on atrial fibrosis in rats with atrial fibrillation
  70. Cholesterol induces inflammation and reduces glucose utilization
  71. circ_0004904 regulates the trophoblast cell in preeclampsia via miR-19b-3p/ARRDC3 axis
  72. NECAB3 promotes the migration and invasion of liver cancer cells through HIF-1α/RIT1 signaling pathway
  73. The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk
  74. miR-2053 inhibits the growth of ovarian cancer cells by downregulating SOX4
  75. Nucleophosmin 1 associating with engulfment and cell motility protein 1 regulates hepatocellular carcinoma cell chemotaxis and metastasis
  76. α-Hederin regulates macrophage polarization to relieve sepsis-induced lung and liver injuries in mice
  77. Changes of microbiota level in urinary tract infections: A meta-analysis
  78. Identification of key enzalutamide-resistance-related genes in castration-resistant prostate cancer and verification of RAD51 functions
  79. Falls during oxaliplatin-based chemotherapy for gastrointestinal malignancies – (lessons learned from) a prospective study
  80. Outcomes of low-risk birth care during the Covid-19 pandemic: A cohort study from a tertiary care center in Lithuania
  81. Vitamin D protects intestines from liver cirrhosis-induced inflammation and oxidative stress by inhibiting the TLR4/MyD88/NF-κB signaling pathway
  82. Integrated transcriptome analysis identifies APPL1/RPS6KB2/GALK1 as immune-related metastasis factors in breast cancer
  83. Genomic analysis of immunogenic cell death-related subtypes for predicting prognosis and immunotherapy outcomes in glioblastoma multiforme
  84. Circular RNA Circ_0038467 promotes the maturation of miRNA-203 to increase lipopolysaccharide-induced apoptosis of chondrocytes
  85. An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy
  86. Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
  87. Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
  88. PTPN12 down-regulated by miR-146b-3p gene affects the malignant progression of laryngeal squamous cell carcinoma
  89. miR-141-3p accelerates ovarian cancer progression and promotes M2-like macrophage polarization by targeting the Keap1-Nrf2 pathway
  90. lncRNA OIP5-AS1 attenuates the osteoarthritis progression in IL-1β-stimulated chondrocytes
  91. Overexpression of LINC00607 inhibits cell growth and aggressiveness by regulating the miR-1289/EFNA5 axis in non-small-cell lung cancer
  92. Subjective well-being in informal caregivers during the COVID-19 pandemic
  93. Nrf2 protects against myocardial ischemia-reperfusion injury in diabetic rats by inhibiting Drp1-mediated mitochondrial fission
  94. Unfolded protein response inhibits KAT2B/MLKL-mediated necroptosis of hepatocytes by promoting BMI1 level to ubiquitinate KAT2B
  95. Bladder cancer screening: The new selection and prediction model
  96. circNFATC3 facilitated the progression of oral squamous cell carcinoma via the miR-520h/LDHA axis
  97. Prone position effect in intensive care patients with SARS-COV-2 pneumonia
  98. Clinical observation on the efficacy of Tongdu Tuina manipulation in the treatment of primary enuresis in children
  99. Dihydroartemisinin ameliorates cerebral I/R injury in rats via regulating VWF and autophagy-mediated SIRT1/FOXO1 pathway
  100. Knockdown of circ_0113656 assuages oxidized low-density lipoprotein-induced vascular smooth muscle cell injury through the miR-188-3p/IGF2 pathway
  101. Low Ang-(1–7) and high des-Arg9 bradykinin serum levels are correlated with cardiovascular risk factors in patients with COVID-19
  102. Effect of maternal age and body mass index on induction of labor with oral misoprostol for premature rupture of membrane at term: A retrospective cross-sectional study
  103. Potential protective effects of Huanglian Jiedu Decoction against COVID-19-associated acute kidney injury: A network-based pharmacological and molecular docking study
  104. Clinical significance of serum MBD3 detection in girls with central precocious puberty
  105. Clinical features of varicella-zoster virus caused neurological diseases detected by metagenomic next-generation sequencing
  106. Collagen treatment of complex anorectal fistula: 3 years follow-up
  107. LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through down-regulating SP-A by sponging to miR-424
  108. Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen – An open-label, randomized trial
  109. SMOC2 plays a role in heart failure via regulating TGF-β1/Smad3 pathway-mediated autophagy
  110. A prospective cohort study of the impact of chronic disease on fall injuries in middle-aged and older adults
  111. circRNA THBS1 silencing inhibits the malignant biological behavior of cervical cancer cells via the regulation of miR-543/HMGB2 axis
  112. hsa_circ_0000285 sponging miR-582-3p promotes neuroblastoma progression by regulating the Wnt/β-catenin signaling pathway
  113. Long non-coding RNA GNAS-AS1 knockdown inhibits proliferation and epithelial–mesenchymal transition of lung adenocarcinoma cells via the microRNA-433-3p/Rab3A axis
  114. lncRNA UCA1 regulates miR-132/Lrrfip1 axis to promote vascular smooth muscle cell proliferation
  115. Twenty-four-color full spectrum flow cytometry panel for minimal residual disease detection in acute myeloid leukemia
  116. Hsa-miR-223-3p participates in the process of anthracycline-induced cardiomyocyte damage by regulating NFIA gene
  117. Anti-inflammatory effect of ApoE23 on Salmonella typhimurium-induced sepsis in mice
  118. Analysis of somatic mutations and key driving factors of cervical cancer progression
  119. Hsa_circ_0028007 regulates the progression of nasopharyngeal carcinoma through the miR-1179/SQLE axis
  120. Variations in sexual function after laparoendoscopic single-site hysterectomy in women with benign gynecologic diseases
  121. Effects of pharmacological delay with roxadustat on multi-territory perforator flap survival in rats
  122. Analysis of heroin effects on calcium channels in rat cardiomyocytes based on transcriptomics and metabolomics
  123. Risk factors of recurrent bacterial vaginosis among women of reproductive age: A cross-sectional study
  124. Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells
  125. Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients
  126. Correlation between microvessel maturity and ISUP grades assessed using contrast-enhanced transrectal ultrasonography in prostate cancer
  127. The protective effect of caffeic acid phenethyl ester in the nephrotoxicity induced by α-cypermethrin
  128. Norepinephrine alleviates cyclosporin A-induced nephrotoxicity by enhancing the expression of SFRP1
  129. Effect of RUNX1/FOXP3 axis on apoptosis of T and B lymphocytes and immunosuppression in sepsis
  130. The function of Foxp1 represses β-adrenergic receptor transcription in the occurrence and development of bladder cancer through STAT3 activity
  131. Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU
  132. Calycosin protects against chronic prostatitis in rats via inhibition of the p38MAPK/NF-κB pathway
  133. Pan-cancer analysis of the PDE4DIP gene with potential prognostic and immunotherapeutic values in multiple cancers including acute myeloid leukemia
  134. The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
  135. Circ-UBR4 regulates the proliferation, migration, inflammation, and apoptosis in ox-LDL-induced vascular smooth muscle cells via miR-515-5p/IGF2 axis
  136. Clinical characteristics of current COVID-19 rehabilitation outpatients in China
  137. Luteolin alleviates ulcerative colitis in rats via regulating immune response, oxidative stress, and metabolic profiling
  138. miR-199a-5p inhibits aortic valve calcification by targeting ATF6 and GRP78 in valve interstitial cells
  139. The application of iliac fascia space block combined with esketamine intravenous general anesthesia in PFNA surgery of the elderly: A prospective, single-center, controlled trial
  140. Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
  141. The effects of progesterone on the healing of obstetric anal sphincter damage in female rats
  142. Identification of cuproptosis-related genes for predicting the development of prostate cancer
  143. Lumican silencing ameliorates β-glycerophosphate-mediated vascular smooth muscle cell calcification by attenuating the inhibition of APOB on KIF2C activity
  144. Targeting PTBP1 blocks glutamine metabolism to improve the cisplatin sensitivity of hepatocarcinoma cells through modulating the mRNA stability of glutaminase
  145. A single center prospective study: Influences of different hip flexion angles on the measurement of lumbar spine bone mineral density by dual energy X-ray absorptiometry
  146. Clinical analysis of AN69ST membrane continuous venous hemofiltration in the treatment of severe sepsis
  147. Antibiotics therapy combined with probiotics administered intravaginally for the treatment of bacterial vaginosis: A systematic review and meta-analysis
  148. Construction of a ceRNA network to reveal a vascular invasion associated prognostic model in hepatocellular carcinoma
  149. A pan-cancer analysis of STAT3 expression and genetic alterations in human tumors
  150. A prognostic signature based on seven T-cell-related cell clustering genes in bladder urothelial carcinoma
  151. Pepsin concentration in oral lavage fluid of rabbit reflux model constructed by dilating the lower esophageal sphincter
  152. The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
  153. Tanshinone IIA attenuates valvular interstitial cells’ calcification induced by oxidized low density lipoprotein via reducing endoplasmic reticulum stress
  154. AS-IV enhances the antitumor effects of propofol in NSCLC cells by inhibiting autophagy
  155. Establishment of two oxaliplatin-resistant gallbladder cancer cell lines and comprehensive analysis of dysregulated genes
  156. Trial protocol: Feasibility of neuromodulation with connectivity-guided intermittent theta-burst stimulation for improving cognition in multiple sclerosis
  157. LncRNA LINC00592 mediates the promoter methylation of WIF1 to promote the development of bladder cancer
  158. Factors associated with gastrointestinal dysmotility in critically ill patients
  159. Mechanisms by which spinal cord stimulation intervenes in atrial fibrillation: The involvement of the endothelin-1 and nerve growth factor/p75NTR pathways
  160. Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics
  161. Silencing USP19 alleviates cigarette smoke extract-induced mitochondrial dysfunction in BEAS-2B cells by targeting FUNDC1
  162. Menstrual irregularities associated with COVID-19 vaccines among women in Saudi Arabia: A survey during 2022
  163. Ferroptosis involves in Schwann cell death in diabetic peripheral neuropathy
  164. The effect of AQP4 on tau protein aggregation in neurodegeneration and persistent neuroinflammation after cerebral microinfarcts
  165. Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
  166. Analysis of clinical characteristics in proximal and distal reflux monitoring among patients with gastroesophageal reflux disease
  167. Exosomal circ-0020887 and circ-0009590 as novel biomarkers for the diagnosis and prediction of short-term adverse cardiovascular outcomes in STEMI patients
  168. Upregulated microRNA-429 confers endometrial stromal cell dysfunction by targeting HIF1AN and regulating the HIF1A/VEGF pathway
  169. Bibliometrics and knowledge map analysis of ultrasound-guided regional anesthesia
  170. Knockdown of NUPR1 inhibits angiogenesis in lung cancer through IRE1/XBP1 and PERK/eIF2α/ATF4 signaling pathways
  171. D-dimer trends predict COVID-19 patient’s prognosis: A retrospective chart review study
  172. WTAP affects intracranial aneurysm progression by regulating m6A methylation modification
  173. Using of endoscopic polypectomy in patients with diagnosed malignant colorectal polyp – The cross-sectional clinical study
  174. Anti-S100A4 antibody administration alleviates bronchial epithelial–mesenchymal transition in asthmatic mice
  175. Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma
  176. Prevalence and antibiogram of bacteria causing urinary tract infection among patients with chronic kidney disease
  177. Reactive oxygen species within the vaginal space: An additional promoter of cervical intraepithelial neoplasia and uterine cervical cancer development?
  178. Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma
  179. A new technique for uterine-preserving pelvic organ prolapse surgery: Laparoscopic rectus abdominis hysteropexy for uterine prolapse by comparing with traditional techniques
  180. Self-isolation of an Italian long-term care facility during COVID-19 pandemic: A comparison study on care-related infectious episodes
  181. A comparative study on the overlapping effects of clinically applicable therapeutic interventions in patients with central nervous system damage
  182. Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome: Long-term follow-up
  183. The diagnostic accuracy of touch imprint cytology for sentinel lymph node metastases of breast cancer: An up-to-date meta-analysis of 4,073 patients
  184. Mortality associated with Sjögren’s syndrome in the United States in the 1999–2020 period: A multiple cause-of-death study
  185. CircMMP11 as a prognostic biomarker mediates miR-361-3p/HMGB1 axis to accelerate malignant progression of hepatocellular carcinoma
  186. Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations
  187. KMT2A maintains stemness of gastric cancer cells through regulating Wnt/β-catenin signaling-activated transcriptional factor KLF11
  188. Evaluation of placental oxygenation by near-infrared spectroscopy in relation to ultrasound maturation grade in physiological term pregnancies
  189. The role of ultrasonographic findings for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer
  190. Construction of immunogenic cell death-related molecular subtypes and prognostic signature in colorectal cancer
  191. Long-term prognostic value of high-sensitivity cardiac troponin-I in patients with idiopathic dilated cardiomyopathy
  192. Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients
  193. Integrative bioinformatics analysis reveals STAT2 as a novel biomarker of inflammation-related cardiac dysfunction in atrial fibrillation
  194. Adipose-derived stem cells repair radiation-induced chronic lung injury via inhibiting TGF-β1/Smad 3 signaling pathway
  195. Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000–2016 cohort
  196. lncRNA LENGA sponges miR-378 to promote myocardial fibrosis in atrial fibrillation
  197. Diagnostic value of urinary Tamm-Horsfall protein and 24 h urine osmolality for recurrent calcium oxalate stones of the upper urinary tract: Cross-sectional study
  198. The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer
  199. The spike protein of SARS-CoV-2 induces inflammation and EMT of lung epithelial cells and fibroblasts through the upregulation of GADD45A
  200. Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
  201. MiR-1278 targets CALD1 and suppresses the progression of gastric cancer via the MAPK pathway
  202. Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson’s disease after dietary supplementation with branched-chain amino acids
  203. Cimifugin inhibits adipogenesis and TNF-α-induced insulin resistance in 3T3-L1 cells
  204. Predictors of gastrointestinal complaints in patients on metformin therapy
  205. Prescribing patterns in patients with chronic obstructive pulmonary disease and atrial fibrillation
  206. A retrospective analysis of the effect of latent tuberculosis infection on clinical pregnancy outcomes of in vitro fertilization–fresh embryo transferred in infertile women
  207. Appropriateness and clinical outcomes of short sustained low-efficiency dialysis: A national experience
  208. miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD
  209. Clinical features and management of lymphoepithelial cyst
  210. Serum VEGF, high-sensitivity CRP, and cystatin-C assist in the diagnosis of type 2 diabetic retinopathy complicated with hyperuricemia
  211. ENPP1 ameliorates vascular calcification via inhibiting the osteogenic transformation of VSMCs and generating PPi
  212. Significance of monitoring the levels of thyroid hormone antibodies and glucose and lipid metabolism antibodies in patients suffer from type 2 diabetes
  213. The causal relationship between immune cells and different kidney diseases: A Mendelian randomization study
  214. Interleukin 33, soluble suppression of tumorigenicity 2, interleukin 27, and galectin 3 as predictors for outcome in patients admitted to intensive care units
  215. Identification of diagnostic immune-related gene biomarkers for predicting heart failure after acute myocardial infarction
  216. Long-term administration of probiotics prevents gastrointestinal mucosal barrier dysfunction in septic mice partly by upregulating the 5-HT degradation pathway
  217. miR-192 inhibits the activation of hepatic stellate cells by targeting Rictor
  218. Diagnostic and prognostic value of MR-pro ADM, procalcitonin, and copeptin in sepsis
  219. Review Articles
  220. Prenatal diagnosis of fetal defects and its implications on the delivery mode
  221. Electromagnetic fields exposure on fetal and childhood abnormalities: Systematic review and meta-analysis
  222. Characteristics of antibiotic resistance mechanisms and genes of Klebsiella pneumoniae
  223. Saddle pulmonary embolism in the setting of COVID-19 infection: A systematic review of case reports and case series
  224. Vitamin C and epigenetics: A short physiological overview
  225. Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients
  226. Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
  227. Mechanism of rhubarb in the treatment of hyperlipidemia: A recent review
  228. Surgical management and outcomes of traumatic global brachial plexus injury: A concise review and our center approach
  229. The progress of autoimmune hepatitis research and future challenges
  230. METTL16 in human diseases: What should we do next?
  231. New insights into the prevention of ureteral stents encrustation
  232. VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature
  233. Case Reports
  234. Mycobacterium xenopi infection of the kidney and lymph nodes: A case report
  235. Genetic mutation of SLC6A20 (c.1072T > C) in a family with nephrolithiasis: A case report
  236. Chronic hepatitis B complicated with secondary hemochromatosis was cured clinically: A case report
  237. Liver abscess complicated with multiple organ invasive infection caused by hematogenous disseminated hypervirulent Klebsiella pneumoniae: A case report
  238. Urokinase-based lock solutions for catheter salvage: A case of an upcoming kidney transplant recipient
  239. Two case reports of maturity-onset diabetes of the young type 3 caused by the hepatocyte nuclear factor 1α gene mutation
  240. Immune checkpoint inhibitor-related pancreatitis: What is known and what is not
  241. Does total hip arthroplasty result in intercostal nerve injury? A case report and literature review
  242. Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi – Case report and literature review
  243. Synchronous triple primary gastrointestinal malignant tumors treated with laparoscopic surgery: A case report
  244. CT-guided percutaneous microwave ablation combined with bone cement injection for the treatment of transverse metastases: A case report
  245. Malignant hyperthermia: Report on a successful rescue of a case with the highest temperature of 44.2°C
  246. Anesthetic management of fetal pulmonary valvuloplasty: A case report
  247. Rapid Communication
  248. Impact of COVID-19 lockdown on glycemic levels during pregnancy: A retrospective analysis
  249. Erratum
  250. Erratum to “Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway”
  251. Erratum to: “Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p”
  252. Retraction
  253. Retraction of “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients”
  254. Retraction of “circ_0062491 alleviates periodontitis via the miR-142-5p/IGF1 axis”
  255. Retraction of “miR-223-3p alleviates TGF-β-induced epithelial-mesenchymal transition and extracellular matrix deposition by targeting SP3 in endometrial epithelial cells”
  256. Retraction of “SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis”
  257. Retraction of “circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury”
  258. Retraction of “lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells”
  259. Special issue Linking Pathobiological Mechanisms to Clinical Application for cardiovascular diseases
  260. Effect of cardiac rehabilitation therapy on depressed patients with cardiac insufficiency after cardiac surgery
  261. Special issue The evolving saga of RNAs from bench to bedside - Part I
  262. FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma
  263. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part III
  264. Development of a machine learning-based signature utilizing inflammatory response genes for predicting prognosis and immune microenvironment in ovarian cancer
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 17.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2023-0640/html
Scroll to top button